Torgerson JS, Hauptman J, Boldrin MN, Sjöström L: XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27:155–161, 2004

In the above-listed article, the final sentence of the conclusions section in the abstract should read: “Difference in diabetes incidence was detectable only in the IGT subgroup; weight loss was similar in subjects with IGT or NGT” (i.e., “IGT or NGT” replaces “IGT and or NGT”).